Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cellebrite DI Q1 Adj. EPS $0.10 Beats $0.08 Estimate, Sales $107.55M Miss $109.36M Estimate

Author: Benzinga Newsdesk | May 14, 2025 06:00am
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 by 25 percent. This is a 25 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $107.55 million which missed the analyst consensus estimate of $109.36 million by 1.65 percent. This is a 20.06 percent increase over sales of $89.58 million the same period last year.

Posted In: CLBT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist